NEU 3.50% $14.05 neuren pharmaceuticals limited

ann: neuren completes enrolment of second pati, page-15

  1. 10,009 Posts.
    really hard to give a firm value. The coy presentations show the NNZ-2566 has a market potential of at least 10 differant uses exceeding $10 Billion dollars in value.

    it will take time to get all approvals throug, and money of course, but will get easier, cheaper and faster with each approval.

    So dilution and partnership factors are not kow.


    But if they succeed to the potential we are hoping, our grandchildren will have bragging rights on how the fa ily made its fortune. of course that is if all goes perfectly over next 6-7 years.

    At this price its one of those bets, the pay-off for such a small buy in makes the high risk and time factor well worth the bet.

    especially when you evaluate how well the company is performing and management that looks outstanding. in a sector that has such a poor track record of producing world class management. NEU seems to have that.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.05
Change
-0.510(3.50%)
Mkt cap ! $1.795B
Open High Low Value Volume
$14.38 $14.42 $13.94 $6.419M 454.6K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.99
 

Sellers (Offers)

Price($) Vol. No.
$14.07 6644 4
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.